Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (35)
Jinpeng Tan, Xingyao Sun, Hongling Zhao, Hua Guan, Shanshan Gao & Ping‐Kun Zhou. (2023) Double‐strand DNA break repair: molecular mechanisms and therapeutic targets. MedComm 4:5.
Crossref
Crossref
Vanessa Klapp, Beatriz Álvarez-Abril, Giuseppe Leuzzi, Guido Kroemer, Alberto Ciccia & Lorenzo Galluzzi. (2023) The DNA Damage Response and Inflammation in Cancer. Cancer Discovery 13:7, pages 1521-1545.
Crossref
Crossref
Linyinxue Dong, Ceeane Paul Dagoc Vargas, Xuechen Tian, Xiayu Chu, Chenqi Yin, Aloysius Wong & Yixin Yang. (2023) Harnessing the Potential of Non-Apoptotic Cell Death Processes in the Treatment of Drug-Resistant Melanoma. International Journal of Molecular Sciences 24:12, pages 10376.
Crossref
Crossref
Yu-Li Su, Ling-Yi Xiao, Shih-Yu Huang, Chia-Che Wu, Li-Chung Chang, Yi-Hua Chen, Hao-Lun Luo, Chun-Chieh Huang, Ting-Ting Liu & Jei-Ming Peng. (2023) Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage Process. Cells 12:11, pages 1471.
Crossref
Crossref
Deqian Xie, Bowen Jiang, Shijin Wang, Qifei Wang & Guangzhen Wu. (2023) The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Wenwen Chien, Jeffrey W. Tyner, Sigal Gery, Yueyuan Zheng, Li-Yan Li, Mohan Shankar Gopinatha Pillai, Chehyun Nam, Neil A. Bhowmick, De-Chen Lin & H. Phillip Koeffler. (2023) Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR. Journal of Ovarian Research 16:1.
Crossref
Crossref
Sushmitha Sriramulu, Shivani Thoidingjam, Stephen L. Brown, Farzan Siddiqui, Benjamin Movsas & Shyam Nyati. (2023) Molecular targets that sensitize cancer to radiation killing: From the bench to the bedside. Biomedicine & Pharmacotherapy 158, pages 114126.
Crossref
Crossref
Qinran Zhang, Suoqin Jin & Xiufen Zou. (2022) scAB detects multiresolution cell states with clinical significance by integrating single-cell genomics and bulk sequencing data. Nucleic Acids Research 50:21, pages 12112-12130.
Crossref
Crossref
Philippa R. Barton, Alexander J. Davenport, Jens Hukelmann, Doreen A. Cantrell, Jane C. Stinchcombe, Arianne C. Richard & Gillian M Griffiths. (2022) Super‐killer CTLs are generated by single gene deletion of Bach2. European Journal of Immunology 52:11, pages 1776-1788.
Crossref
Crossref
Lindsey Carlsen & Wafik S. El-Deiry. (2022) Anti-cancer immune responses to DNA damage response inhibitors: Molecular mechanisms and progress toward clinical translation. Frontiers in Oncology 12.
Crossref
Crossref
Jason M. Redman, Jay Friedman, Yvette Robbins, Cem Sievers, Xinping Yang, Wiem Lassoued, Andrew Sinkoe, Antonios Papanicolau-Sengos, Chyi-Chia Lee, Jennifer L. Marte, Evrim Turkbey, Wojtek Mydlarz, Arjun Joshi, Nyall R. LondonJr.Jr., Matthew Pierce, Rodney Taylor, Steven Hong, Andy Nguyen, Patrick Soon-Shiong, Jeffrey Schlom, James L. Gulley & Clint T. Allen. (2022) Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer. Journal of Clinical Investigation 132:18.
Crossref
Crossref
Michihisa Kono, Shin Saito, Ann Marie Egloff, Clint T. Allen & Ravindra Uppaluri. (2022) The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations. Oral Oncology 132, pages 106012.
Crossref
Crossref
Bingchen Pan, Bowen Zheng, Chengzhong Xing & Jingwei Liu. (2022) Non-Canonical Programmed Cell Death in Colon Cancer. Cancers 14:14, pages 3309.
Crossref
Crossref
Aisha Hussein Al‐Jamaei, Jan G. A. M. de Visscher, V. Ramadugula Subramanyam, Tymour Forouzanfar, Peter Sminia, Behrouz Zandieh Doulabi & Marco N. Helder. (2022)
WEE1
kinase inhibitor
MK
‐1775 sensitizes oral tongue squamous cell carcinoma cells to radiation irrespective of
TP53
status
. Oral Diseases.
Crossref
Crossref
Zhengbo Hu, Ramya Viswanathan, Hui Cheng, Jianghong Chen, Xinping Yang, Angel Huynh, Paul Clavijo, Yi An, Yvette Robbins, Christopher Silvin, Clint Allen, Pinar Ormanoglu, Scott Martin, Shaleeka Cornelius, Anthony Saleh, Zhong Chen, Carter Van Waes & Ethan L. Morgan. (2022) Inhibiting WEE1 and IKK-RELA Crosstalk Overcomes TNFα Resistance in Head and Neck Cancers. Molecular Cancer Research 20:6, pages 867-882.
Crossref
Crossref
Xiaowu Qian, Chun Jiang, Zhengtai Zhu, Gaohua Han, Ning Xu, Jun Ye & Ruixing Wang. (2022) Long non-coding RNA LINC00511 facilitates colon cancer development through regulating microRNA-625-5p to target WEE1. Cell Death Discovery 8:1.
Crossref
Crossref
Xiangbing Meng, Jason Z. Gao, Sean Michael T. Gomendoza, John W. Li & Shujie Yang. (2021) Recent Advances of WEE1 Inhibitors and Statins in Cancers With p53 Mutations. Frontiers in Medicine 8.
Crossref
Crossref
Mei-Hua Jin, Ah-Rong Nam, Ju-Hee Bang, Kyoung-Seok Oh, Hye-Rim Seo, Jae-Min Kim, Jeesun Yoon, Tae-Yong Kim & Do-Youn Oh. (2021) WEE1 inhibition reverses trastuzumab resistance in HER2-positive cancers. Gastric Cancer 24:5, pages 1003-1020.
Crossref
Crossref
Myrto Moutafi, Panagiota Economopoulou, David Rimm & Amanda Psyrri. (2021) PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical data. Oral Oncology 117, pages 105292.
Crossref
Crossref
Julian A. Marin-Acevedo, ErinMarie O. Kimbrough, Rami Manochakian, Yujie Zhao & Yanyan Lou. (2021) Immunotherapies targeting stimulatory pathways and beyond. Journal of Hematology & Oncology 14:1.
Crossref
Crossref
Andrew J Charap, Tomohiro Enokida, Rachel Brody, John Sfakianos, Brett Miles, Nina Bhardwaj & Amir Horowitz. (2020) Landscape of natural killer cell activity in head and neck squamous cell carcinoma. Journal for ImmunoTherapy of Cancer 8:2, pages e001523.
Crossref
Crossref
Ahmed Diab, Hakan Gem, Jherek Swanger, Hee Yeon Kim, Kaleb SmithGrace ZouSharat RajuMichael KaoMatthew FitzgibbonKeith R. Loeb, Cristina P. Rodriguez, Eduardo MéndezDenise A. Galloway, Julia M. SidorovaBruce E. Clurman. (2020) FOXM1 drives HPV+ HNSCC sensitivity to WEE1 inhibition. Proceedings of the National Academy of Sciences 117:45, pages 28287-28296.
Crossref
Crossref
Carmelina Antonella Iannuzzi, Paola Indovina, Iris Maria Forte, Sarah Di Somma, Anna Maria Malfitano, Martina Bruno, Giuseppe Portella, Francesca Pentimalli & Antonio Giordano. (2020) Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the dl922-947 Oncolytic Virus in Malignant Mesothelioma Cell Lines. International Journal of Molecular Sciences 21:19, pages 7333.
Crossref
Crossref
W.F. Yang, N. Qin, X. Song, C. Jiang, T. Li, P. Ji, Y. Li, D. Ding, C. Wang, J. Dai, G. Jin, T.W. Chen, Y.S. Chang, D.Q. Ouyang, G.Q. Liao, Z. Hu, K.P. Chang, Y.X. Su & H. Ma. (2020) Genomic Signature of Mismatch Repair Deficiency in Areca Nut–Related Oral Cancer. Journal of Dental Research 99:11, pages 1252-1261.
Crossref
Crossref
Hui Yi Chew, Riccardo Dolcetti & Fiona Simpson. (2020) Scientifically based combination therapies with immuno‐oncology checkpoint inhibitors. British Journal of Clinical Pharmacology 86:9, pages 1711-1725.
Crossref
Crossref
Bin Wang, Lin Sun, Zhiyong Yuan & Zhen Tao. (2020) Wee1 kinase inhibitor AZD1775 potentiates CD8+ T cell-dependent antitumour activity via dendritic cell activation following a single high dose of irradiation. Medical Oncology 37:8.
Crossref
Crossref
Yvette Robbins, Sarah Greene, Jay Friedman, Paul E Clavijo, Carter Van Waes, Kellsye P Fabian, Michelle R Padget, Houssein Abdul Sater, John H Lee, Patrick Soon-Shiong, James Gulley, Jeffrey Schlom, James W Hodge & Clint T Allen. (2020) Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells. eLife 9.
Crossref
Crossref
Rui-Xue Huang & Ping-Kun Zhou. (2020) DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref
Ah-Rong Nam, Mei-Hua Jin, Ju-Hee Bang, Kyoung-Seok Oh, Hye-Rim Seo, Do-Youn Oh & Yung-Jue Bang. (2020) Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer. Cancer Research and Treatment.
Crossref
Crossref
Jay Friedman, Ellen C. Moore, Paul Zolkind, Yvette Robbins, Paul E. Clavijo, Lilian Sun, Sarah Greene, Megan V. Morisada, Wojciech K. Mydlarz, Nicole Schmitt, James W. Hodge, Hans Schreiber, Carter Van Waes, Ravindra Uppaluri & Clint Allen. (2020) Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells. Clinical Cancer Research 26:3, pages 679-689.
Crossref
Crossref
Matthew T. McMillan, Theodore S. Lawrence & Meredith A. Morgan. 2020. Molecular Targeted Radiosensitizers. Molecular Targeted Radiosensitizers
191
218
.
Thomas Powles, Mark Kockx, Alejo Rodriguez-Vida, Ignacio Duran, Simon J. Crabb, Michiel S. Van Der Heijden, Bernadett Szabados, Albert Font Pous, Gwenaelle Gravis, Urbano Anido Herranz, Andrew Protheroe, Alain Ravaud, Denis Maillet, Maria Jose Mendez, Cristina Suarez, Mark Linch, Aaron Prendergast, Pieter-Jan van Dam, Diana Stanoeva, Sofie Daelemans, Sanjeev Mariathasan, Joy S. Tea, Kelly Mousa, Romain Banchereau & Daniel Castellano. (2019) Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial. Nature Medicine 25:11, pages 1706-1714.
Crossref
Crossref
Ishani Das, Margareta Wilhelm, Veronica Höiom, Rodolfo Franco Marquez, Fernanda Costa Svedman, Johan Hansson, Rainer Tuominen & Suzanne Egyhàzi Brage. (2019) Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF/NRAS mutation status. Cell Death & Disease 10:9.
Crossref
Crossref
Sarah Greene, Priya Patel & Clint T. Allen. (2019) How patients with an intact immune system develop head and neck cancer. Oral Oncology 92, pages 26-32.
Crossref
Crossref
Lillian Sun, Paul E. Clavijo, Yvette Robbins, Priya Patel, Jay Friedman, Sarah Greene, Rita Das, Chris Silvin, Carter Van Waes, Lucas A. Horn, Jeffrey Schlom, Claudia Palena, Dean Maeda, John Zebala & Clint T. Allen. (2019) Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy. JCI Insight 4:7.
Crossref
Crossref